267 results on '"Mouillac, Bernard"'
Search Results
2. Fluorescent-Based Strategies to Investigate G Protein-Coupled Receptors: Evolution of the Techniques to a Better Understanding
3. Biased Agonist Pharmacochaperones: Small Molecules in the Toolbox for Selectively Modulating GPCR Activity
4. Pharmacological Chaperones as Potential Therapeutic Strategies for Misfolded Mutant Vasopressin Receptors
5. Green mamba peptide targets type-2 vasopressin receptor against polycystic kidney disease
6. Bringing GPCR Structural Biology to Medical Applications: Insights from Both V2 Vasopressin and Mu-Opioid Receptors
7. Biased activation of the vasopressin V2 receptor probed by NMR, paramagnetic ligands, and molecular dynamics simulations
8. Vasopressin and oxytocin receptors in GtoPdb v.2023.1
9. Design, synthesis and biological studies of a library of NK1-Receptor Ligands Based on a 5-arylthiosubstituted 2-amino-4,6-diaryl-3-cyano-4H-pyran core: Switch from antagonist to agonist effect by chemical modification
10. Misfolding of vasopressin receptors: biased agonist pharmacochaperones as potential therapeutics
11. Time-Resolved FRET-Based Assays to Characterize G Protein-Coupled Receptor Hetero-oligomer Pharmacology
12. Ghrelin receptor conformational dynamics regulate the transition from a preassembled to an active receptor : Gq complex
13. Structure of the vasopressin hormone–V2 receptor–β-arrestin1 ternary complex
14. V1b vasopressin receptor trafficking and signaling: Role of arrestins, G proteins and Src kinase
15. Pharmacological Chaperones as Potential Therapeutic Strategies for Misfolded Mutant Vasopressin Receptors
16. Biased Agonist Pharmacochaperones: Small Molecules in the Toolbox for Selectively Modulating GPCR Activity
17. Fluorescent-Based Strategies to Investigate G Protein-Coupled Receptors: Evolution of the Techniques to a Better Understanding
18. Heterodimerization with Its Splice Variant Blocks the Ghrelin Receptor 1a in a Non-signaling Conformation: A STUDY WITH A PURIFIED HETERODIMER ASSEMBLED INTO LIPID DISCS*
19. Distinct roles of metabotropic glutamate receptor dimerization in agonist activation and G-protein coupling
20. Structural insights into biased G protein-coupled receptor signaling revealed by fluorescence spectroscopy
21. A new Kunitz‐type snake toxin family associated with an original mode of interaction with the vasopressin 2 receptor
22. Functional Rescue of a Nephrogenic Diabetes Insipidus Causing Mutation in the V2 Vasopressin Receptor by Specific Antagonist and Agonist Pharmacochaperones
23. Amphipols in G Protein-Coupled Receptor Pharmacology: What Are They Good For?
24. THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: G protein‐coupled receptors
25. Carbohydrate-Based NK1R Antagonists with Broad-Spectrum Anticancer Activity
26. A new Kunitz-type snake toxin family associated with an original mode of interaction with the vasopressin 2 receptor.
27. Cryo–electron microscopy structure of the antidiuretic hormone arginine-vasopressin V2 receptor signaling complex
28. Vasopressin receptors and pharmacological chaperones: From functional rescue to promising therapeutic strategies
29. TR-FRET Between Engineered Nanobodies Reveals Existence of Endogenous CXCR4 Oligomers
30. The ligand-bound state of a G protein-coupled receptor stabilizes the interaction of functional cholesterol molecules
31. THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein-coupled receptors
32. The two NK-1 binding sites correspond to distinct, independent, and non-interconvertible receptor conformational states as confirmed by plasmon-waveguide resonance spectroscopy
33. Structure of the antidiuretic hormone vasopressin receptor signalling complex
34. Time Resolved FRET Strategy with Fluorescent Ligands to Analyze Receptor Interactions in Native Tissues: Application to GPCR Oligomerization
35. Molecular pharmacology of vasopressin receptors
36. Mammalian Membrane Receptors Expression as Inclusion Bodies in Escherichia coli
37. A snake toxin as a theranostic agent for the type 2 vasopressin receptor
38. V-1B Vasopressin Receptor
39. V-2 Vasopressin Receptor
40. OT Oxytocin Receptor
41. Vasopressin-Oxytocin Receptors
42. Inhibition of oxytocin receptor function by direct binding of progesterone
43. Chapter 13 Expression of human vasopressin and oxytocin receptors in Escherichia coli
44. Oxytocin and Vasopressin V1a and V2 Receptors Form Constitutive Homo- and Heterodimers during Biosynthesis
45. [24] Dynamic palmitoylation of G-protein-coupled receptors in eukaryotic cells
46. Vasopressin and oxytocin receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database
47. LIT-001, the First Nonpeptide Oxytocin Receptor Agonist that Improves Social Interaction in a Mouse Model of Autism
48. Crystal structure and functional domains of the Mambaquaretin-1, a vasopressin type 2 receptor peptide inhibitor for kidney cysts treatment
49. V1b vasopressin receptor trafficking and signaling: Role of arrestins, G proteins and Src kinase
50. Design, synthesis and biological studies of a library of NK1-Receptor Ligands Based on a 5-arylthiosubstituted 2-amino-4,6-diaryl-3-cyano-4 H -pyran core: Switch from antagonist to agonist effect by chemical modification
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.